Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer
Titel:
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer
Auteur:
Harvey-Jones, E. Raghunandan, M. Robbez-Masson, L. Magraner-Pardo, L. Alaguthurai, T. Yablonovitch, A. Yen, J. Xiao, H. Brough, R. Frankum, J. Song, F. Yeung, J. Savy, T. Gulati, A. Alexander, J. Kemp, H. Starling, C. Konde, A. Marlow, R. Cheang, M. Proszek, P. Hubank, M. Cai, M. Trendell, J. Lu, R. Liccardo, R. Ravindran, N. Llop-Guevara, A. Rodriguez, O. Balmana, J. Lukashchuk, N. Dorschner, M. Drusbosky, L. Roxanis, I. Serra, V. Haider, S. Pettitt, S.J. Lord, C.J. Tutt, A.N.J.